Patient NAVIgation to Reduce Readmissions Among Black Men With Heart Disease
NCT ID: NCT02340364
Last Updated: 2019-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
301 participants
INTERVENTIONAL
2015-03-31
2019-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nurse-Led Heart Failure Care Transition Intervention for African Americans: The Navigator Program
NCT01141907
PATient Navigator to rEduce Readmissions
NCT02114515
A Family Intervention for Improving Self-Care of Patients With Heart Failure
NCT00645489
Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care
NCT00508508
Teach-Back Discharge Education to Improve Self-Care and Reduce 30-Day Readmissions in Heart Failure Patients
NCT07280208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To assess the 30-day all-cause readmission rates among male African American Heart Disease patients receiving Heart Disease self-care education plus a patient navigator-delivered self-care plan versus Heart Disease self-care education alone
2. To assess the Heart Disease self-efficacy and heart failure self-care adherence among male African American Heart Disease patients receiving Heart Disease self-care education plus a patient navigator-delivered self-care plan versus Heart Disease self-care education alone
3. To evaluate the cost-effectiveness of Heart Disease self-care education plus a patient navigator-delivered self-care plan versus Heart Disease self-care education alone
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Education + PN Arm
208 patients randomized to self-care education+ Patient navigator-delivered self-care plan.
Education + Patient Navigation
208 patients randomized to self-care Education+ Patient Navigation-delivered self-care plan.
Educational Control Arm
\- 208 patients randomized to self-care education alone.
Self-care Education
208 patients randomized to self-care education alone.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education + Patient Navigation
208 patients randomized to self-care Education+ Patient Navigation-delivered self-care plan.
Self-care Education
208 patients randomized to self-care education alone.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male
* Age = 30 or older
* Inpatient admission at UAB Hospital or UAB Medical West with a diagnosis of heart disease as a principle or one of the first 3 diagnosis.
* Residence in Jefferson or Shelby Counties, Alabama within 45 miles of UAB Hospital.
* English Speaking
* Physically and cognitively able to listen to 30-minute video undergo a home visit and telephone contacts over several weeks.
Exclusion Criteria
* Currently participating in another clinical research study with an overlapping intervention.
* Current or anticipated long term (\>2 weeks) residence in a skilled nursing facility.
* Patients who indicated that they were unwilling to make lifestyle changes now or in the near future.
* Patients whose symptoms may be eliminated by surgery (e.g., severe aortic stenosis) or who had undergone surgery (e.g., coronary artery bypass grafting valvular replacement/repair) in the last month.
30 Years
90 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reagan W. Durant, MD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raegan W Durant, M.D., MPH
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UAB Medical West
Bessemer, Alabama, United States
UAB
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
X130515002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.